Abstract:Background: Several studies documented the non-hematologic clinical therapeutic uses of recombinant human erythropoietin (EPO). On the other hand, hypertension, thromboembolism, and increased oxidative stress were toxic effects related to the increased hematocrit (Hct) with recombinant human EPO treatment. Accordingly, alternate strategies to reduce erythropoietic activity and other potential side effects of EPO will greatly improve its non-hematopoietic clinical applicability. Aims and Objectives: Our objecti… Show more
“…decreased WBCs, neutrophils, and monocytes (Memarzia et al, 2021), eosinophils, MCV, MCH (Jantawong et al, 2021) and MCHC levels. Cur significantly increased RBCs, HB, PLTs, and HCT in agreement with (Manju et al, 2013 andHussain et al, 2017).…”
“…decreased WBCs, neutrophils, and monocytes (Memarzia et al, 2021), eosinophils, MCV, MCH (Jantawong et al, 2021) and MCHC levels. Cur significantly increased RBCs, HB, PLTs, and HCT in agreement with (Manju et al, 2013 andHussain et al, 2017).…”
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.